PDS Stock Recent News

PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced patient recruitment has been completed in Stage 1 of a clinical trial of the Company's PDS01ADC therapeutic administered systemically in combination with floxuridine (FUDR) administered by hepatic artery infusion pump (HAIP) for patients with metastatic colorectal cancer (NCT05286814), led by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH).

Explore the booming Global Deep Hole Drilling Machine Market, poised to surge from USD 1.13 Billion in 2025 to USD 1.77 Billion by 2034, a 6.6% CAGR growth. Essential for precision sectors like aerospace and automotive, these machines integrate Industry 4.0, offering innovation and intelligence for modern manufacturing. Explore the booming Global Deep Hole Drilling Machine Market, poised to surge from USD 1.13 Billion in 2025 to USD 1.77 Billion by 2034, a 6.6% CAGR growth. Essential for precision sectors like aerospace and automotive, these machines integrate Industry 4.0, offering innovation and intelligence for modern manufacturing.

CALGARY, Alberta, July 02, 2025 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) intends to release its 2025 second quarter results after the market closes on Tuesday, July 29, 2025, and has scheduled a conference call to begin at 11:00 a.m. MT (1:00 p.m. ET) on the next day, Wednesday, July 30, 2025.

Scale, innovation and disciplined execution help PTEN, RIG, and PDS stand out in a slumping drilling industry.

Event to Discuss the Changing Landscape of HNSCC in context with the Merck KN-689 study and the Rapidly Increasing Incidences of HPV16-positive HNSCC in the United States and Europe

PDS Biotech announced the publication of three Versamune® HPV abstracts that were presented during the Head and Neck Cancer Poster Session at ASCO 2025.

Oil drilling activity in the U.S. will be cut back due to low prices. However, drilling in Canada is robust due to structural factors, at least for now. Precision Drilling gets 2/3 of its revenue from Canada and may weather the downturn better than its U.S. focused competitors.

Phase 2: Versamune ® HPV with pembrolizumab as 1L treatment of r/m HPV16-positive HNSCC

PRINCETON, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech will participate in a fireside chat during the Alliance Global Partners (“A.G.P.”) Virtual Annual Healthcare Company Showcase, taking place May 21, 2025.

CALGARY, Alberta, May 15, 2025 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision or the Company) is pleased to announce the results of the election of board members at its 2025 Annual and Special Meeting of Shareholders held on May 15, 2025 (the Annual Meeting). Shareholders approved the election of all eight (seven of whom are independent) of the nominee directors presented in the Company's Management Information Circular (the Circular), dated April 2, 2025.